Copyright
©The Author(s) 2017.
World J Orthop. Dec 18, 2017; 8(12): 946-955
Published online Dec 18, 2017. doi: 10.5312/wjo.v8.i12.946
Published online Dec 18, 2017. doi: 10.5312/wjo.v8.i12.946
Table 1 Data from primary total knee arthroplasty randomized controlled trials
Paper | AIBC group number of TKAs infected | Infection rate of AIBC group | Non-AIBC number of TKAs infected | Infection rate of non-AIBC group | Reason for procedure | Follow-up (mo) |
Chiu et al[18], 2001 | 0/41 | 0 | 5/37 | 0.13514 | Osteoarthritis | 50 |
Vrabec et al[23], 2016 | 0/10 | 0 | 0/5 | 0 | N/A | 12 |
Chiu et al[19], 2002 | 0/178 | 0 | 5/162 | 0.03086 | N/A | 49 |
Lizaur-Utrilla et al[24], 2014 | 1/48 | 0.020833 | 0/45 | 0 | Non-inflammatory arthritis | 76.8 |
Nilsson et al[25], 1999 | 0/28 | 0 | 2/29 | 0.068966 | Osteoarthritis and Rheumatoid arthritis | 60 |
Bercovy et al[26] , 2012 | 2/164 | 0.012195 | 1/157 | 0.006369 | N/A | 91.2 |
Hinarejos et al[20], 2013 | 20/1483 | 0.013486 | 20/1465 | 0.013652 | N/A | 38 |
McQueen et al[22], 1987 | 0/13 | 0 | 1/13 | 0.076923 | Osteoarthritis and rheumatoid arthritis | 24 |
McQueen et al[21], 1990 | 0/14 | 0 | 1/11 | 0.090909 | Osteoarthritis | 24 |
Total: 23/1979 (1.16%) | Total: 35/1924 (1.82%) | Average: 47.2 |
Table 2 Data from revision TKA RCTs
Paper | AIBC group number of TKAs infected | Infection rate of AIBC group | Non-AIBC number of TKAs infected | Infection rate of non-AIBC group | Reason for procedure | Follow-up (mo) |
Nelson et al[27], 1993 | 0/3 | 0 | 0/3 | 0 | Previous infection | 36 |
Chiu et al[17], 2009 | 0/93 | 0 | 7/90 | 7.78% | Osteoarthritis | 89 |
Total: 0/96 (0.00%) | Total: 7/93 (7.53%) | Average: 62.5 |
Table 3 Comparisons made between groups in primary TKA RCTs
Paper | Comparison |
Chiu et al[18], 2001 | Cefuroxime-impregnated cement vs PBC |
Vrabec et al[23], 2016 | Intravenous tobramycin vs AIBC with tobramycin |
Chiu et al[19], 2002 | Cefuroxime-impregnated cement vs PBC |
Lizaur-Utrilla et al[24], 2014 | Tibial fixation with either a cemented (Palacos with Gentamicin) vs cementless with screw augmentation (systemic antibiotics only) |
Nilsson et al[25], 1999 | Vacuum mixed bone cement (Palacos–Gentamicin) vs hydroxyapatite-coated prostheses |
Bercovy et al[26], 2012 | Hydroxyapatite-coated prostheses vs cemented (Refobacin) tibial components |
Hinarejos et al[20], 2013 | Simplex P cement loaded with 0.5 g of erythromycin and three million units of colistin in 40 g of cement (Stryker) vs simplex cement without antibiotic |
McQueen et al[22], 1987 | Cefuroxime in bone cement (1.5 g of cefuroxime powder was added to 40 g of CMW cement powder) vs systemic (1.5 g) cefuroxime |
McQueen et al[21], 1990 | Cefuroxime in bone cement (1.5 g of cefuroxime powder was added to 40 g of CMW cement powder) vs systemic (1.5 g) cefuroxime |
Table 4 Comparisons made between groups in revision TKA RCTs
Table 5 HSS, KSS knee scores, and loosening rates
Paper | Statistically significant differences in deep infection rate | HSS knee score AIBC | HSS knee score non-AIBC | KSS score AIBC | KSS score non-AIBC | Loosening AIBC | Loosening non-AIBC |
Chiu et al[18], 2001 | Yes (P = 0.021) | 91 | 86 | - | - | 0/41 | 2/37 |
Vrabec et al[23], 2016 | No (P value not reported) | - | - | - | - | - | - |
Chiu et al[19], 2002 | Yes (P = 0.0238) | 90 | 88 | - | - | 1/178 | 0/162 |
Lizaur-Utrilla et al[24], 2014 | No (P value not reported) | - | - | 89 | 94 | 4/48 | 1/45 |
Nilsson et al[25], 1999 | No (P value not reported) | - | - | 93 | 93 | 0/28 | 1/29 |
Bercovy et al[26], 2012 | No (P value not reported) | - | - | 94.3 | 94.6 | 1/164 | 1/157 |
Hinarejos et al[20], 2013 | No (P = 0.96) | - | - | - | - | - | - |
McQueen et al[22], 1987 | No (P value not reported) | - | - | - | - | - | - |
McQueen et al[21], 1990 | No (P value not reported) | - | - | - | - | - | - |
Nelson et al[27], 1993 | No (P value not reported) | - | - | - | - | - | - |
Chiu et al[17], 2009 | Yes (P = 0.0130) | 87 | 85 | - | - | 0/93 | 0/90 |
- Citation: Kleppel D, Stirton J, Liu J, Ebraheim NA. Antibiotic bone cement’s effect on infection rates in primary and revision total knee arthroplasties. World J Orthop 2017; 8(12): 946-955
- URL: https://www.wjgnet.com/2218-5836/full/v8/i12/946.htm
- DOI: https://dx.doi.org/10.5312/wjo.v8.i12.946